PAVmed (PAVM) Income from Continuing Operations (2016 - 2025)

PAVmed's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 2757000.0 for Q4 2025.

• On a quarterly basis, Income from Continuing Operations fell 341.42% year-over-year to 2757000.0 in Q4 2025; TTM through Dec 2025 was 2469000.0, a 95.03% increase from a year earlier, with the FY2025 full-year figure at 2469000.0, down 108.69% from the prior year.
• Income from Continuing Operations climbed to 2757000.0 in Q4 2025 per PAVM's latest filing, from 6011000.0 in the prior quarter.
• Across five years, Income from Continuing Operations topped out at 18623000.0 in Q1 2025 and bottomed at 29932000.0 in Q3 2022.
• The 5-year median for Income from Continuing Operations is 17408000.0 (2023), against an average of 14388526.32.
• Biggest YoY gain for Income from Continuing Operations was 200.6% in 2025; the steepest drop was 341.42% in 2025.
• Year by year, Income from Continuing Operations stood at 19679000.0 in 2021, then declined by 24.86% to 24572000.0 in 2022, then climbed by 29.16% to 17408000.0 in 2023, then surged by 106.56% to 1142000.0 in 2024, then sank by 341.42% to 2757000.0 in 2025.
• Per Business Quant, the three latest PAVM Income from Continuing Operations figures stand at 2757000.0 (Q4 2025), 6011000.0 (Q3 2025), and 12324000.0 (Q2 2025).